VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) dropped 8.7% on Tuesday . The company traded as low as C$0.09 and last traded at C$0.11. Approximately 288,748 shares traded hands during mid-day trading, an increase of 140% from the average daily volume of 120,081 shares. The stock had previously closed at C$0.12.
VentriPoint Diagnostics Price Performance
The firm has a 50 day moving average of C$0.12 and a 200-day moving average of C$0.11. The company has a market cap of C$18.06 million, a P/E ratio of -3.50 and a beta of -0.60. The company has a current ratio of 0.28, a quick ratio of 6.67 and a debt-to-equity ratio of -58.56.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients.
Featured Articles
- Five stocks we like better than VentriPoint Diagnostics
- Silver $500? The “Deficit Math” says it’s possible.
- SELL Alert: Oracle Corporation (ORCL)
- Elon Musk already made me a “wealthy man”
- The Foundation Behind Today’s Biggest Tech Trends
- Elon Musk: This Could Turn $100 into $100,000
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
